Find information about ZOSTAVAX® (Zoster Vaccine Live) for Health Care Professionals including Prescribing Information and Patient Information. Get information about the single-shot Shingles shot. Learn more about a Shingles vaccine and learn who is at risk for getting Shingles. 5 Jul Post-Marketing Adverse Drug Reactions); however, ZOSTAVAX® II is not This leaflet is part III of a three-part “Product Monograph”.
|Published (Last):||17 July 2015|
|PDF File Size:||7.65 Mb|
|ePub File Size:||19.82 Mb|
|Price:||Free* [*Free Regsitration Required]|
Studies are ongoing to assess the duration of protection from one dose of zoster vaccine and zotsavax need, zostavax package insert any, for booster doses. Standing orders for administering zoster vaccine to adults.
Use this handout to teach patients about the seriousness of shingles and the value of vaccination [ P]. The vaccine should be administered immediately after reconstitution to minimize loss of potency.
However, it is not necessary to repeat ijsert if it is administered intramuscularly. Any zostavax package insert vaccine should be discarded if not used within 30 minutes.
zostavax package insert
Zoster Vaccine – Patient Information Handouts – Shingles Vaccine Information
Vaccine Storage and Handling. January 25, Content source: There are no comprehensive data on the effectiveness of zoster vaccine in treating shingles once it occurs, and the vaccine is not licensed for this use.
But anyone with a moderate or severe acute illness should usually wait until they recover before zostavax package insert the vaccine. No data are available about the effectiveness of zoster vaccine in adults who become immunosuppressed after their vaccination.
Persons who report that they have not had varicella can still zostavax package insert the zoster vaccine. If the error is not immediately detected, a dose of zoster vaccine should be administered as soon as possible but not within 28 days zostavax package insert the varicella vaccine dose to prevent potential interference of 2 doses of live attenuated virus. Laboratory testing to determine if there is evidence of past infection with varicella zoster virus is not necessary.
For people 50 through 59 years old, the risk of getting zoster and having prolonged pain from post-herpetic neuralgia caused by zoster is much lower than for people 60 years old and older.
For example, if the patient has. This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases Grant No. Unprotected People Reports – Shingles zoster.
Eligible health professionals may vaccinate adults who meet any of the criteria on zostavax package insert form [ P]. Zoster vaccine should not be used in children and should not be used in place of varicella vaccine.
Also, varicella vaccine should not be used in place of zoster vaccine. Standing Orders for Vaccination. Healthcare providers considering zoster vaccine zostavax package insert certain people 50 through 59 years old should discuss the risks and benefits of vaccination with their patients.
The vaccine should not be injected intramuscularly. National Center for Immunization and Respiratory Diseases. This includes anyone with a temperature of In people vaccinated at 60 years old or older, vaccine efficacy wanes within the first 5 years after vaccination, and protection beyond 5 years is uncertain.
CDC recommends a single dose of herpes zoster vaccine for people 60 years of age or olderwhether or not zostavax package insert person reported a prior episode of zoster. If packagr erroneous dose was administered in lieu of the first dose of varicella vaccine, a second dose of varicella vaccine zostavax package insert required at the normal time a second dose would be given.
In the event that varicella ;ackage was accidentally administered to an adult 60 years of age or older instead of zoster vaccine, Advisory Committee on Immunization Practices states: Repeated zoster has been confirmed in immunocompetent persons, including soon after a previous episode.
When administering zoster vaccine to people 60 years of age or older, there zostavax package insert no need to ask for a packate zostavax package insert varicella or to conduct laboratory testing for serologic evidence of prior varicella-zoster virus infection.
Information about the disease and vaccine for patients and parents [ P]. Skip directly to search Skip zpstavax to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content. Although the precise risk for and severity of zoster as a function of time following an earlier episode are unknown, some studies suggest it may be comparable to the risk in zostavax package insert without a history of zoster.
Zoster vaccine zostavax package insert administered subcutaneously as a single dose. Recommend on Facebook Tweet Share Compartir. If serologic testing is conducted and there is evidence of varicella susceptibility, the patient should be offered varicella vaccine not zoster vaccine.
Vaccine Information Statements – Shingles zoster. Zoster vaccine, a live virus vaccine, can be administered concurrently with all other live and inactivated vaccines, including those routinely recommended for people 60 years of age or older, such as influenza and pneumococcal vaccines. Inseert the vaccine has short-term efficacy, there have been no long-term studies of vaccine protection in this age zostavax package insert.